Banner
Share

Research

In Developmental Medicine, we remain committed to advancing care through rigorous clinical and scientific research.

In collaboration with Albert Einstein College of Medicine’s Children's Evaluation and Rehabilitation Center (CERC), our team has launched an array of research initiatives, many focused on investigating the underlying causes of autism, learning disabilities, cerebral palsy and other developmental disabilities.

These efforts have a clear, unswerving goal: to find cures and more effective treatments for these conditions by identifying their genetic, neurologic, physiologic and environmental etiologies. Once we understand these causes, the medical community will be empowered to take on these disabilities at the source, rather than treat the symptoms.

Beyond finding the bases of these problems, our research aims to evaluate and increase the efficacy of currently used treatments. We’re also actively involved in studies on physical rehabilitation, speech pathology, hearing and language development, social and behavioral adjustment, learning disabilities and more.

The Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (IDDRC)

Specializing in intellectual and developmental disabilities in children and adolescents, the Rose F. Kennedy IDDRC serves as our central hub of research labs and patient clinics. For more than four decades, the IDDRC has been a vanguard of new research on brain development and function. Bridging the gap between academic research and clinical care, the scientists at IDDRC contribute landmark research on autism, Rett syndrome, Fragile X syndrome, Niemann-Pick C, seizure disorders, deafness, communication disorders and more.

The Rose F. Kennedy University Center for Excellence in Developmental Disabilities (UCEDD)

The Rose F. Kennedy UCEDD is dedicated to improving the lives of those with developmental disabilities. Along with offering direct services and providing interdisciplinary training, the UCEDD’s research focuses on creating, implementing and evaluating family-oriented strategies. By sharing this applied research openly with aligned agencies, Einstein’s UCEDD aims to enhance access to cutting-edge care for underserved communities.

Meet Sophie Molhom, director for research at CERC

Active Clinical Trials

Trial Description
Disease / Condition
Principal Investigator
Contact
Trial DescriptionA Double Blind, Randomized, Placebo-Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin (FCT) - Click here for more informationIRB# 14-10-543
Disease/ConditionAutism
Principal InvestigatorEric Hollander, MD
Contact Bonnie Taylor, Ph.D.
(718) 920-2909
Email Contact
Trial DescriptionA Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy - Click here for more informationIRB# 14-10-443
Disease/ConditionBrain and Neurological
Sleep-Wake Disorders
Principal InvestigatorMichael Thorpy, MD
Contact Shelby Harris
(718) 920-4841
Email Contact
Trial DescriptionActive commuting to school and behavior problems among school-aged children IRB# 2014-4362
Disease/ConditionChild Development
Principal InvestigatorRuth Stein, MD
Contact Mana Mann
(718) 839-7025
Email Contact
Trial DescriptionAre children with Autistic Spectrum Disorder diagnosed before 2 years of age different clinically from older children diagnosed after 2 years of age? IRB# 2005-785
Disease/ConditionAutism
Principal InvestigatorMaria Valicenti-McDermott, MD
Contact Maria Valicenti-McDermott, MD
(718) 430-8600 Ext 6275
Email Contact
Trial DescriptionAutism Genetics Network, Phase II: Increasing Representation of Human Diversity IRB# 2012-537
Disease/ConditionAutism
Principal InvestigatorSophie Molholm, PhD
Contact Danielle DeMaio
(718) 862-1860
Email Contact
Trial DescriptionClinical characterization of the pre-ictal state in the pediatric population: A caretaker's perspective on seizure prediction IRB# 2013-2455
Disease/ConditionBrain and Neurological
Principal InvestigatorSheryl Haut, MD
Contact Puja Patel
(917) 205-7283
Email Contact
Trial DescriptionEfficacy of Group Attachment Based Intervention for Vulnerable Families - Click here for more informationIRB# 2005-703
Disease/ConditionChild Development
Principal InvestigatorAnne Murphy, PhD
Contact Anne Murphy, PhD
(718) 839-7265
Email Contact
Trial DescriptionExploring Brain Responses to Affective Images in Mothers with High or Low Adverse Childhood Experiences (Aces) IRB# 2014-3334
Disease/ConditionChild Development
Principal InvestigatorAnne Murphy, PhD
Contact Anne Murphy, PhD
(718) 839-7265
Email Contact
Trial DescriptionFollow-up study of children with early diagnosis of autism spectrum disorder IRB# 2007-546
Disease/ConditionAutism
Principal InvestigatorLisa Shulman, MD
Contact Lisa Shulman, MD
(718) 430-3901
Email Contact
Trial DescriptionInfantile Spasms Multicenter Database IRB# 13-01-027
Disease/ConditionBrain and Neurological
Principal InvestigatorElissa Yozawitz, MD
Contact Elissa Yozawitz, MD
(718) 920-4378
Email Contact
Trial DescriptionMaintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma - Click here for more informationIRB# 10-07-196
Disease/ConditionBrain and Neurological
Principal InvestigatorJonathan Gill, MD
Contact Joyce Brown
(718) 741-2356
Email Contact
Trial DescriptionSelf regulation in children with learning disabilities and inattention/hyperactivity IRB# 2006-425
Disease/ConditionChild Development
Principal InvestigatorKatherine Lawson, PhD
Contact Maria Valicenti-McDermott, MD
(718) 430-8600 6275
Email Contact
Trial DescriptionSensory Integration Therapy in Autism: Mechanisms and Effectiveness IRB# 2014-3795
Disease/ConditionAutism
Principal InvestigatorSophie Molholm, PhD
Contact Maya Madzharova
(718) 862-1817
Email Contact
Trial DescriptionStudy to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters - Click here for more informationOCT11-0108B; IRB# 11-10-322
Disease/ConditionBrain and Neurological
Principal InvestigatorAlexis Boro, MD
Contact Elan Shoulders, MPH
(718) 920-2898
Email Contact
Trial DescriptionStudy to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters (ARTEMIS1) - Click here for more informationIRB# 11-10-127
Disease/ConditionBrain and Neurological
Principal InvestigatorAlexis Boro, MD
Contact Elan Shoulders
(718) 920-2898
Email Contact
Trial DescriptionThe use of Complementary and Alternative Medicine in Autism IRB# 2007-371
Disease/ConditionAutism
Principal InvestigatorMaria Valicenti-McDermott, MD
Contact Maria Valicenti-McDermott, MD
(718) 430-8600 Ext 6275
Email Contact
Trial DescriptionThe use of Virtual Reality Games to Enhance Therapy for Children with Cerebral Palsy. A pilot Study IRB# 2008-347
Disease/ConditionBrain and Neurological
Principal InvestigatorMaria Valicenti-McDermott, MD
Contact Maria Valicenti-McDermott, MD
(718) 430-8600 Ext 6275
Email Contact
View all Clinical Trials